🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hypertrophic Cardiomyopathy (HCM) is a relatively common inherited heart mu...
Status
Completed
Location
heart Hospital, University College of London NHS
Start Date
2006-12
Trial ID
NCT00500552
Treatments Being Tested
Open-heart surgery causes injury of the heart muscle. Although this is usua...
Status
Completed
Location
University Hospital Birmingham
Start Date
2007-02
Trial ID
NCT00845364
Treatments Being Tested
Diabetes increases the risk of heart failure. This is mainly due to a disea...
Status
Unknown
Location
University of Birmingham
Start Date
2006-10
Trial ID
NCT00628056
Treatments Being Tested
Hypertrophic Cardiomyopathy (HCM) is the most common inherited heart muscle...
Status
Unknown
Location
Flinders Medical Centre
Start Date
2020-12-01
Trial ID
NCT04426578
Treatments Being Tested
A Study on the Efficacy, Safety, and Tolerability of Perhexiline maleate in...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02431221
Treatments Being Tested
The purpose of this study is to evaluate the effect of perhexiline on exerc...
Status
Terminated
Location
Multiple Locations
Start Date
2016-08-01
Trial ID
NCT02862600
Treatments Being Tested
Up to half of all patients with clinical features of heart failure are foun...
Status
Completed
Location
University of Aberdeen
Start Date
2009-03
Trial ID
NCT00839228
Treatments Being Tested
Open-heart surgery causes injury of the heart muscle. Although this is usua...
Status
Unknown
Location
University Hospital Birmingham
Start Date
2009-10
Trial ID
NCT00989508
Treatments Being Tested
Conventional measures used for the treatment of chronic heart failure act p...
Status
Completed
Location
University Hospitals Brimingham NHS Foundation Trust
Start Date
2009-02
Trial ID
NCT00841139
Treatments Being Tested